MicroRNA-1469-5p promotes the invasion and proliferation of pancreatic cancer cells via direct regulating the NDRG1/NF-κB/E-cadherin axis

被引:0
作者
Jinju Liu
Chaoyu Zhu
Lingzhi Zhang
Hongmei Lu
Zhen Wang
Jian Lv
Changru Fan
机构
[1] Linyi Cancer Hospital,Department of Internal Medicine
[2] Linyi Cancer Hospital,Department of Abdominal Surgery
来源
Human Cell | 2020年 / 33卷
关键词
Pancreatic cancer; microRNA-1469-5p; NF-κb; NDRG1;
D O I
暂无
中图分类号
学科分类号
摘要
Numerous studies demonstrated that microRNAs (miRNAs) were highly involved in pancreatic cancer development. However, the functional roles of many miRNAs remain elusive in pancreatic cancer. In the present study, we analyzed previous published microarray data and found that miR-1469-5p was one of top upregulated miRNAs in pancreatic tumors. Our further study showed that miR-1469-5p was highly expressed in collected pancreatic tumors and its upregulation was associated with lymph node metastasis and tumors of advanced TNM stage. Functional analysis with miR-1469-5p inhibitor showed that downregulation of miR-1469-5p repressed pancreatic cancer cell proliferation and invasion. Mechanistically, miR-1469-5p directly interacted with metastasis suppressor NDRG1 mRNA and downregulated expression of NDRG1 to activate NF-κB pathway in pancreatic cancer cells. It was also found that miR-1469-5p decreased expression of E-cadherin, a metastasis related gene repressed by NF-κB pathway, in pancreatic cancer cells. Transfection of NDRG1 small interference RNA (siRNA) attenuated the function of miR-1469-5p inhibitor in pancreatic cancer cells. Moreover, miR-1469-5p expression was negatively associated with NDRG1 and E-cadherin mRNA levels in pancreatic tumors. Taken together, miR-1469-5p may exert its oncogenic potential in pancreatic cancer via regulating a NDRG1/NF-κB/E-cadherin axis, suggesting that it may be clinically valuable as a prognostic biomarker of pancreatic cancer.
引用
收藏
页码:1176 / 1185
页数:9
相关论文
共 98 条
[1]  
Siegel RL(2019)Cancer statistics, 2019 CA Cancer J Clin 69 7-34
[2]  
Miller KD(2019)Epidemiology of pancreatic cancer: global trends, etiology and risk factors World J Oncol 10 10-27
[3]  
Jemal A(2007)Surgery for recurrent pancreatic ductal adenocarcinoma Ann Surg 245 566-572
[4]  
Rawla P(2013)Brain metastasis in pancreatic cancer Int J Mol Sci 14 4163-4173
[5]  
Sunkara T(2016)The role of MicroRNAs in human cancer Signal Transduct Target Ther 1 15004-193
[6]  
Gaduputi V(2018)Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: a miRNA expression analysis Gene 673 181-82871
[7]  
Kleeff J(2017)MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1 Oncotarget 8 82854-324
[8]  
Reiser C(2018)MicroRNAs in pancreatic cancer diagnosis and therapy Cent Eur J Immunol 43 314-62
[9]  
Hinz U(2020)PRMT1 promotes pancreatic cancer growth and predicts poor prognosis Cell Oncol (Dordr) 43 51-308
[10]  
Lemke J(2017)MicroRNA-148a suppresses epithelial-mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/beta-catenin signaling pathway Oncol Rep 38 301-334